Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Montréal

$25,281.06

Role of the alternative splicing factor Nova2 in the development and function of layer 5 pyramidal neurons

EF 2024-25

Résumé
Cortical pyramidal neurons are the most abundant neurons in the cortex, with layer 5 (L5) pyramidal neurons (PNs) being the main output layer. These neurons are the only neocortical cell type with dendrites spanning all six cortical layers, making them one of the main integrators in the cortical column. The laminar structure of the mammalian brain is generated by waves of neuronal migration that are coordinated in time and space. Although recent progress has shed light on the molecular mechanisms that orchestrate these processes, the role that post-transcriptional regulation of RNA plays in L5 PN development and function remains ill-defined. Nova proteins were the first mammalian neuron-specific splicing factors identified. Despite abundant data showing Nova2-mediated alternative splicing of neuronal proteins, it has been challenging to establish the role of each splicing event in-vivo and therefore its physiological relevance. The exceptions being the finding that a) Nova2 is required for cortical layering of migrating neurons through the alternative splicing regulation of Disabled-1, a key molecule in the Reelin pathway, and  b) Nova2 mediates axonal pathfinding via alternative splicing of the netrin receptor DCC. Our unpublished observations of L5 PNs in Nova2KO mice show distinctive abnormal phenotypes: 1) Cortical misplacement, 2) defects in somatic morphology/polarity, 3) impaired dendritic development, 4) aberrant dendritic spine formation/density, 5) impaired axonal pathfinding, and 6) increased action potential threshold. These data suggest that proteins regulated by Nova2 control different aspects of neuronal development and function, and that the Nova2KO mouse represents an unprecedented tool to do a molecular dissection of the alternative-splicing events necessary for normal cortical development in-vivo. Hence, our hypothesis is that Nova2-mediated alternative splicing of key structural and synaptic proteins is required for L5 PNs migration, development, intrinsic electrophysiological properties and synaptic function. The first aim of the proposal is to study the role of Nova2 in L5 PNs morphology including polarity, axonal and dendritic development and the second aim is to establish the role of Nova2 in L5 PNs intrinsic electrophysiological properties and synaptic function. To determine how Nova2-mediated splicing of key proteins orchestrates the development and function of L5 PNs we will use a multifaceted approach including state of-the-art optical, electrophysiological, genetic and molecular tools. In particular, we will tap into our database of Nova2-regulated targets to select specific splice variants to be expressed in L5 PNs of control mice and we will perform phenotype-rescue experiments in two genetic mouse models with total or partial Nova2 deletion. We expect that these findings will shed light into the mechanisms of cortical development and ultimately in understanding the development and function of the main output neuron of the neocortex.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2022-04275
Name nom
Araya, Roberto
Department département
Neurosciences
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
25281.06
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5305
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Protein manipulation and expression
Research subject fr
Expression et recombinaison protéiques
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Role of the alternative splicing factor Nova2 in the development and function of layer 5 pyramidal neurons
Keywords
neocortex; pyramidal neuron; dendrites; alternative-splicing; nova2; two-photon imaging; cortical development; layer 5 pyramidal neuron; electrophysiology; two-photon uncaging
Application summary
Cortical pyramidal neurons are the most abundant neurons in the cortex, with layer 5 (L5) pyramidal neurons (PNs) being the main output layer. These neurons are the only neocortical cell type with dendrites spanning all six cortical layers, making them one of the main integrators in the cortical column. The laminar structure of the mammalian brain is generated by waves of neuronal migration that are coordinated in time and space. Although recent progress has shed light on the molecular mechanisms that orchestrate these processes, the role that post-transcriptional regulation of RNA plays in L5 PN development and function remains ill-defined. Nova proteins were the first mammalian neuron-specific splicing factors identified. Despite abundant data showing Nova2-mediated alternative splicing of neuronal proteins, it has been challenging to establish the role of each splicing event in-vivo and therefore its physiological relevance. The exceptions being the finding that a) Nova2 is required for cortical layering of migrating neurons through the alternative splicing regulation of Disabled-1, a key molecule in the Reelin pathway, and  b) Nova2 mediates axonal pathfinding via alternative splicing of the netrin receptor DCC. Our unpublished observations of L5 PNs in Nova2KO mice show distinctive abnormal phenotypes: 1) Cortical misplacement, 2) defects in somatic morphology/polarity, 3) impaired dendritic development, 4) aberrant dendritic spine formation/density, 5) impaired axonal pathfinding, and 6) increased action potential threshold. These data suggest that proteins regulated by Nova2 control different aspects of neuronal development and function, and that the Nova2KO mouse represents an unprecedented tool to do a molecular dissection of the alternative-splicing events necessary for normal cortical development in-vivo. Hence, our hypothesis is that Nova2-mediated alternative splicing of key structural and synaptic proteins is required for L5 PNs migration, development, intrinsic electrophysiological properties and synaptic function. The first aim of the proposal is to study the role of Nova2 in L5 PNs morphology including polarity, axonal and dendritic development and the second aim is to establish the role of Nova2 in L5 PNs intrinsic electrophysiological properties and synaptic function. To determine how Nova2-mediated splicing of key proteins orchestrates the development and function of L5 PNs we will use a multifaceted approach including state of-the-art optical, electrophysiological, genetic and molecular tools. In particular, we will tap into our database of Nova2-regulated targets to select specific splice variants to be expressed in L5 PNs of control mice and we will perform phenotype-rescue experiments in two genetic mouse models with total or partial Nova2 deletion. We expect that these findings will shed light into the mechanisms of cortical development and ultimately in understanding the development and function of the main output neuron of the neocortex.